BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome: Homologous recombination deficiency (HRD) resulting from inactivation of BRCA1/2 genes promotes chromosomal instability and renders tumor cells susceptible to platinum derivatives and PARP inhibitors (PARPi).